Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001073526 | SCV001239073 | pathogenic | Retinal dystrophy | 2019-05-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001092289 | SCV001248716 | pathogenic | not provided | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001378742 | SCV001576381 | pathogenic | Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2022-11-01 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1331 of the CRB1 protein (p.Arg1331Cys). This variant is present in population databases (rs760544654, gnomAD 0.009%). This missense change has been observed in individuals with CRB1-related conditions (PMID: 24535598, 24811962; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 865928). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CRB1 protein function. For these reasons, this variant has been classified as Pathogenic. |
Institute of Medical Genetics and Applied Genomics, |
RCV001696228 | SCV001916498 | pathogenic | Retinitis pigmentosa | 2021-09-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003455325 | SCV004180218 | pathogenic | Leber congenital amaurosis 8 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003455326 | SCV004180219 | pathogenic | Pigmented paravenous retinochoroidal atrophy | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003455324 | SCV004180220 | pathogenic | Retinitis pigmentosa 12 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003455325 | SCV004211167 | pathogenic | Leber congenital amaurosis 8 | 2023-07-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005012536 | SCV005637139 | likely pathogenic | Pigmented paravenous retinochoroidal atrophy; Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2024-03-14 | criteria provided, single submitter | clinical testing |